T1	HMM 4 23	efficacy and safety
T2	HMM 199 218	safety and efficacy
T3	HMM 647 747	rate of biopsy-confirmed acute rejection (BCAR) and renal function, as measured by serum creatinine.
T4	HMM 824 828	BCAR
T5	HMM 935 956	Mean serum creatinine
T6	HMM 1039 1063	and creatinine clearance
T7	HMM 1215 1228	respectively.
T8	HMM 1229 1255	Patient and graft survival
T9	HMM 1300 1338	differences in infection or malignancy
T10	HMM 1429 1528	excellent 12-month patient and graft survival, a low incidence of BCAR, and improved renal function
T11	HMM 1622 1648	adequate immunosuppression
T12	HMM 1678 1721	for the nephrotoxic effects of cyclosporine
